Krystal Biotech (KRYS) Profit After Tax Growth (1y) (2017 - 2026)
Krystal Biotech (KRYS) Profit After Tax Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 111.59% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Krystal Biotech | 9.84 Bn | 9.02 Bn | 110.08 Mn | 54.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.03% |
| Dec 31, 2025 | 13.02% |
| Sep 30, 2025 | 170.63% |
| Jun 30, 2025 | 146.23% |
| Mar 31, 2025 | 3,796.24% |
| Dec 31, 2024 | 444.92% |
| Sep 30, 2024 | -63.62% |
| Jun 30, 2024 | 146.88% |
| Mar 31, 2024 | 102.06% |
| Dec 31, 2023 | 126.04% |
| Sep 30, 2023 | 370.65% |
| Jun 30, 2023 | -18.15% |
| Mar 31, 2023 | 9.34% |
| Dec 31, 2022 | -45.99% |
| Sep 30, 2022 | -91.03% |
| Jun 30, 2022 | -71.78% |
| Mar 31, 2022 | -215.99% |
| Dec 31, 2021 | -111.25% |
| Sep 30, 2021 | -62.22% |
| Jun 30, 2021 | -139.47% |